Clinical Trial: Clinical efficacy and safety of human-engineered extracellular matrix (ECM) for the treatment of androgenetic alopecia (China)

China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical efficacy and safety of human-engineered extracellular matrix (ECM) for the treatment of androgenetic alopecia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134458

Registration Time: 2026/10/15

Type: Interventional study

Primary Sponsor: The 909th Hospital / Dongnan Hospital of Xiamen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=320778

Published by HT Digital Content Services with permission from Health Daily Digest....